Journal of Stroke & Cerebrovascular Diseases
Volume 12, Issue 1 , Pages 22-28 , January 2003

Development and validation of a model to estimate stroke incidence in a population

  • Brigitte Schau, MD, PhD

      Affiliations

    • Boehringer Ingelheim GmbH, Ingelheim, Germany
    • ,
  • Gudrun Boysen, MD, PhD

      Affiliations

    • Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark
    • ,
  • Thomas Truelsen, MD, PhD

      Affiliations

    • Institute of Preventive Medicine at Kommunehospitalet Copenhagen, Denmark
    • ,
  • Bernadette Boden-Albala, MPH

      Affiliations

    • Department of Neurology
    • ,
  • Jianfeng Cheng, MD, MS

      Affiliations

    • Department of Neurology
    • ,
  • Emily Babamoto, PharmD

      Affiliations

    • Protocare Sciences, Santa Monica, CA
    • ,
  • Carol Zaher, MD, MBA, MPH

      Affiliations

    • Protocare Sciences, Santa Monica, CA
    • ,
  • Ralph L. Sacco, MD, MS

      Affiliations

    • Neurological Institute at Columbia University, New York, NY

Received 9 April 2002 ,Accepted 1 November 2002.

References 

  1. Sudlow CLM, Warlow CP. Comparing stroke incidence worldwide. Stroke. 1996;27:550–558
  2. Fustinoni O, Biller J. Ethnicity and stroke: Beware of the fallacies. Stroke. 2000;31:1013–1015
  3. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet. 1997;349:1269–1276
  4. Eastern Stroke and Coronary Heart Disease Collaborative Research Group . Blood pressure, cholesterol and stroke in eastern Asia. Lancet. 1998;352:1801–1807
  5. Anderson CS, Jamrozik KD, Burvill PW, et al.  Ascertaining the true incidence of stroke: Experience from the Perth Community Stroke Study, 1989-1990. Med J Aust. 1993;158:80–84
  6. Asian Acute Stroke Advisory Panel . Stroke epidemiological data of nine Asian countries. J Med Assoc Thai. 2000;83:1–7
  7. Thorvaldsen P, Asplund K, Kuulasmaa K, et al.  Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26:361–367
  8. Bamford J, Sandercock P, Martin D, et al.  A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-86. J Neurol Neurosurg Psychiatry. 1988;51:1373–1380
  9. Brown RD, Whisnant JP, Sicks JD, et al.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373–380
  10. Wolf PA, DAgostino RB, Belanger AJ, et al.  Probability of stroke: A risk profile from the Framingham Study. Stroke. 1991;22:312–318
  11. Brown RD, Petty GW, OFallon M, et al.  Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke. 1998;29:2109–2113
  12. www.americanheart.org
  13. www.stroke.org
  14. Sacco RL, Boden-Albala B, Gan R, et al, and the Northern Manhattan Stroke Study Collaborators . Stroke incidence among white, black, and Hispanic residents of an urban community. Am J Epidemiol. 1998;147:259–268
  15. Sacco RL, Roberts JK, Boden-Albala B, et al.  Race-ethnicity and determinants of carotid atherosclerosis in a multi-ethnic population: The Northern Manhattan Stroke Study. Stroke. 1997;27:929–935
  16. Boysen G, Nyboe J, Appleyard M, et al.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1345–1353
  17. Appleyard M, Hansen AT, Schnohr P, et al.  The Copenhagen City Heart Study: Osterbroundersogelsen. A book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-1983). Scan J Soc Med. 1989;170(suppl 4):1–160
  18. Truelsen T, Prescott E, Gronbaek M, et al.  Trends in stroke incidence. The Copenhagen City Heart Study. Stroke. 1997;28:1903–1907
  19. www.who.int
  20. Ricci S, Celani MG, LaRosa F, et al.  SEPIVAC: A community-based study of stroke incidence in Umbria, Italy. J Neurol Neurosurg Psychiatry. 1991;54:695–698
  21. Wolfe CDA, Taub NA, Woodrow J, et al.  Patterns of acute stroke care in three districts of southern England. J Epidemiol Comm Health. 1993;47:144–148
  22. Di Carlo A, Launer LJ, Breteler MMB, et al.  Frequency of stroke in Europe: A collaborative study of population-based cohorts. Neurology. 2000;54(suppl 5):S28–S33
  23. Phillip DS. Risk factors for stroke. Can J Cardiol. 1999;15:102G–105G
  24. Gorelick PB. Stroke prevention. Arch Neurol. 1995;52:347–355
  25. Klungel OH, Stricker BHC, Paes AHP, et al.  Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke. 1999;30:1312–1318
  26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991;22:983–988
  27. Kannel WB, Wolf PA, Benjamin EJ, et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol. 1998;82:2N–9N
  28. Brown RD, Whisnant JP, Sicks JRD, et al.  A population-based study of first-ever and total stroke incidence rates in Rochester, Minnesota: 1990-1994. Stroke. 2000;31:279
  29. Schmidt R, Breteler MMB, Inzitari D, et al.  Prognosis with stroke in Europe: A collaborative study of population-based cohorts. Neurology. 2000;54(suppl 5):S34–S37

☆ Supported by Boehringer Ingelheim, GmbH, Ingelheim, Germany. The Northem Manhattan Stroke Study is supported by grants from NINDS (R01 NS 27517, 29993). The majority of the work was performed at Protocare Sciences in Santa Monica, CA.

☆☆ Address reprint requests to: Carol Zaher, MD, MBA, MPH, Protocare Sciences, 2400 Broadway, Suite 100, Santa Monica, CA 90404.

PII: S1052-3057(02)45906-X

doi: 10.1053/jscd.2003.6

Journal of Stroke & Cerebrovascular Diseases
Volume 12, Issue 1 , Pages 22-28 , January 2003

Article Tools